Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

NCT02431143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Visceral Leishmaniasis

Interventions

DRUG: Miltefosine

Sponsor

Drugs for Neglected Diseases